Overview
Felisa Leguizamon practices in Argentina. Leguizamon is rated as an Advanced expert by MediFind in the treatment of COVID-19. Their top areas of expertise are Multiple Sclerosis (MS), Optic Neuritis, Neuromyelitis Optica, and Transverse Myelitis.
Their clinical research consists of co-authoring 34 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of COVID-19.
Locations
Cordoba, X, Argentina
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Multiple Sclerosis (MS)Leguizamon isDistinguished. Learn about Multiple Sclerosis (MS).
- Neuromyelitis OpticaLeguizamon isDistinguished. Learn about Neuromyelitis Optica.
- Optic NeuritisLeguizamon isDistinguished. Learn about Optic Neuritis.
- Advanced
- COVID-19Leguizamon isAdvanced. Learn about COVID-19.
- Relapsing Multiple Sclerosis (RMS)
- Transverse MyelitisLeguizamon isAdvanced. Learn about Transverse Myelitis.
- Experienced
- MyelitisLeguizamon isExperienced. Learn about Myelitis.